Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-12-001490
Filing Date
2012-05-17
Accepted
2012-05-17 14:18:26
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 JINZANGHUANG-TIBET PHARMACEUTICALS, INC. 10Q 2012-03-31 jinsan10q.htm 10-Q 450996
2 RULE 13A-14(A) CERTIFICATION ? CEO jinsan10qexh311.htm EX-31.1 11132
3 RULE 13A-14(A) CERTIFICATION ? CFO jinsan10qexh312.htm EX-31.2 11635
4 RULE 13A-14(B) CERTIFICATION jinsan10qexh321.htm EX-32.1 7178
  Complete submission text file 0001096906-12-001490.txt   1328239

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT jzhg-20120331.xml EX-101.INS 105752
6 XBRL SCHEMA DOCUMENT jzhg-20120331.xsd EX-101.SCH 8352
7 XBRL CALCULATION LINKBASE DOCUMENT jzhg-20120331_cal.xml EX-101.CAL 4766
8 XBRL DEFINITION LINKBASE DOCUMENT jzhg-20120331_def.xml EX-101.DEF 41867
9 XBRL LABELS LINKBASE DOCUMENT jzhg-20120331_lab.xml EX-101.LAB 76029
10 XBRL PRESENTATION LINKBASE DOCUMENT jzhg-20120331_pre.xml EX-101.PRE 54057
Mailing Address HARBORSIDE FINANCIAL CENTER 2500 PLAZA V JERSEY CITY NJ 07311
Business Address HARBORSIDE FINANCIAL CENTER 2500 PLAZA V JERSEY CITY NJ 07311 201-882-3332
JINZANGHUANG TIBET PHARMACEUTICALS, INC. (Filer) CIK: 0000910832 (see all company filings)

EIN.: 262443288 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-53254 | Film No.: 12851446
SIC: 6770 Blank Checks